Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/6620 stock hub

TPEX/6620 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6620is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6620

In the news

Latest news · TPEX/6620

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E14.6

P25 14.4P50 18P75 31.9

ROE17.1

P25 -16.2P50 0.3P75 9.8

ROIC38.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6620 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

TWD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 8B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0006620008
Last refreshed	2026-05-10
Market cap	TWD 11.7B
Price	TWD 70.7
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/6620
Website	https://www.handapharma.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.41%
EV Earnings	10.73x
EV/EBIT	8.61x
EV/EBITDA	7.33x
EV/FCF	35.49x
EV/Sales	4.65x
FCF yield	1.94%
P/B ratio	2.07x
P/E ratio	14.64x
P/S ratio	6.77x
PE Ratio3 Y	34.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	54.02%
EBITDA Margin	62.77%
FCF margin	13.11%
Gross margin	84.53%
Gross Profit	TWD 1.5B
Gross Profit Growth	76.22%
Gross Profit Growth Q	39.54%
Gross Profit Growth3 Y	101.39%
Gross Profit Growth5 Y	121.47%
Net Income	TWD 749.8M
Net Income Growth	58.6%
Net Income Growth Q	62.67%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Pretax Margin	54.18%
Profit Margin	43.36%
Profitable Years	3
ROA	12.51
Roa5y	1.06
ROCE	16.18
ROE	17.08
Roe5y	3.76
ROIC	38.05
Roic5y	18.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.81%
Cagr3y	-24.49%
Cagr5y	22.15%
EPS Growth	44.18
EPS Growth Q	44.64
EPS Growth Quarters	5
EPS Growth Years	1
FCF Growth	-53.72%
FCF Growth Q	50.97%
OCF Growth	-51.04%
OCF Growth Q	47.71%
Revenue Growth	108.18x
Revenue Growth Q	59.45x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	106.05x
Revenue Growth5 Y	126.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.37
Assets	TWD 5.9B
Cash	TWD 3.7B
Current Assets	TWD 4.3B
Current Liabilities	TWD 117.8M
Debt	TWD 47.6M
Debt EBITDA	TWD 0.04
Debt Equity	TWD 0.01
Debt FCF	TWD 0.21
Equity	TWD 5.7B
Interest Coverage	900.9
Liabilities	TWD 232.1M
Long Term Assets	TWD 1.6B
Long Term Liabilities	TWD 114.2M
Net Cash	TWD 3.7B
Net Cash By Market Cap	TWD 31.24
Net Cash Growth	104.32%
Net Debt EBITDA	TWD -3.37
Net Debt Equity	TWD -0.65
Net Debt FCF	TWD -16.13
Tangible Book Value	TWD 4.9B
Tangible Book Value Per Share	TWD 29.57
WACC	8.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	36.59
Net Working Capital	TWD 501.1M
Quick ratio	36.41
Working Capital	TWD 4.2B
Working Capital Turnover	TWD 0.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.09%
Dividend Growth	0%
Dividend Growth Years	2%
Dividend per share	TWD 2
Dividend Years	2
Dividend Yield	2.83%
Last Dividend	TWD 1.51
Payout Ratio	31.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.81%
200-day SMA	93.91
3Y total return	-56.95%
50-day SMA	74.36
50-day SMA vs 200-day SMA	50under200
5Y total return	171.86%
All Time High	221
All Time High Change	-68.01%
All Time High Date	2023-02-24
All Time Low	15.45
All Time Low Change	357.61%
All Time Low Date	2020-03-30
ATR	2.45
Beta	0.8
Beta1y	1
Beta2y	1.13
Ch YTD	-17.79
High	70.7
High52	154
High52 Date	2025-10-14
High52ch	-54.09%
Low	69.7
Low52	67.3
Low52 Date	2026-03-31
Low52ch	5.05%
Ma50ch	-4.92%
Price vs 200-day SMA	-24.72%
RSI	38.07
RSI Monthly	42.18
RSI Weekly	38.09
Sharpe ratio	0.07x
Sortino ratio	0.27
Total Return	-7.26%
Tr YTD	-17.79
Tr1m	3.97%
Tr1w	-4.59%
Tr3m	-8.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 934.2M
Operating Income Growth	123.5
Operating Income Growth Q	74.08
Operating margin	54.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,014,537%
Net Borrowing	-13,260,000
Shares Insiders	1.52%
Shares Institutions	2.19%
Shares Out	165,530,100
Shares Qo Q	1.63%
Shares Yo Y	10.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 210.3M
Average Volume	622,849.6x
Bv Per Share	34.2
CAPEX	TWD -16.9M
Ch1m	3.97
Ch1w	-4.59
Ch1y	-3.55
Ch3m	-8.77
Ch3y	-58.65
Ch5y	157.6
Ch6m	-42.52
Change	0%
Change From Open	0.71
Close	70.7
Days Gap	-0.71
Depreciation Amortization	151,245,000
Dollar Volume	29,097,292
Earnings Date	2026-05-14
EBIT	TWD 934.2M
EBITDA	TWD 1.1B
EPS	TWD 4.83
F Score	5
FCF	TWD 226.7M
FCF EV Yield	2.82x
FCF Per Share	TWD 1.37
Financing CF	1,791,657,000
Fiscal Year End	December
Founded	2,014
Goodwill	35,892,000
Graham Number	60.96101
Graham Upside	-13.78
Income Tax	TWD 187.2M
Investing CF	-847,843,000
Is Primary Listing	1
Last Earnings Date	2025-12-26
Last Report Date	2025-12-31
Ma150	96.75
Ma150ch	-26.92%
Ma20	74.89
Ma20ch	-5.59%
Net CF	1,209,832,000
Next Earnings Date	2026-05-14
Open	70.2
P FCF Ratio	51.62
P OCF Ratio	48.04
Payment Date	2025-07-25
Position In Range	100
Ppne	84,856,000
Price Date	2026-05-08
Price EBITDA	TWD 10.78
Ptbv Ratio	2.39
Relative Volume	0.67x
Revenue	1,729,252,000x
SBC By Revenue	0.95x
Share Based Comp	16,386,000
Tax By Revenue	10.83x
Tax Rate	19.98%
Tr6m	-42.52%
Volume	411,560
Z Score	38.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/6620 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.8%

$2.00 annual per share

Payout ratio

+31.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

-7.3%

Dividend yield + buyback yield combined

Performance

TPEX/6620 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6620?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.2%

Share of float held by funds and institutions

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.1%

Negative means the company is buying back shares.

Technical

TPEX/6620 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.1

Neutral momentum band

Price vs 200-day MA

-24.7%

50/200-day relationship not available

Beta (5Y)

0.80

Less volatile than the market

Sharpe ratio

0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6620

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6620 stock rating?

tpex/6620 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6620 analysis?

The full report lives at /stocks/tpex/6620/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6620?

The latest report frames tpex/6620 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6620 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.